Epperly Melissa B, bought ROIV
October 20, 2025 · Form 4 insider transaction
Epperly Melissa B, bought 1,056 shares of Roivant Sciences Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,056
Price
$0.00
Total value
N/A
InsiderEpperly Melissa B,
RoleDirector
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateOctober 20, 2025
Filing dateOctober 22, 2025
Shares owned after56,904
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects an award of Common Shares received pursuant to the Issuer's Non-Employee Director Compensation Plan that was fully vested as of the grant date.